Introduction – In the medical device industry, few topics create as much confusion as the difference between Intended Use and Indications for Use. Although the two terms appear similar—and are even used interchangeably in casual conversations—they have distinct regulatory meanings and significant implications throughout the device lifecycle.

These definitions are critical because they directly influence:
✔ Device classification
✔ Clinical evidence requirements
✔ Labeling and promotional claims
✔ Regulatory pathways (EU MDR, US FDA, CDSCO)
✔ Benefit–risk analysis
✔ Post-market obligations

A misunderstanding at this stage can lead to costly redesigns, regulatory rejection, or compliance issues later. In this blog, we break down these concepts in simple language, supported by practical examples, to help manufacturers, consultants, and regulatory professionals use them correctly and confidently.

1. What Is Intended Use?

Intended Use describes the general purpose of the device—its overall medical objective. It defines what the device is fundamentally meant to do.

In regulatory terms, Intended Use answers the question:

“Why does this device exist?”

It outlines:

• The broad medical purpose
• The level of impact on patient care
• The mechanism or general principle of action
• Whether the device has therapeutic, diagnostic, monitoring, or preventive roles

Example (General Purpose):

• A thermometer: “To measure body temperature.”
• A surgical mask: “To provide a physical barrier to reduce transfer of microorganisms.”
• A stent: “To maintain patency of a vessel.”

The Intended Use does not go into details like patient population, disease stage, or environment of use. It stays at the macro purpose level.

Why Intended Use Matters

Regulators use the Intended Use to determine:

• The initial risk class
• Whether the device falls under a specific rule (e.g., MDR Annex VIII)
• Whether the product is even categorized as a medical device
• The type of clinical data needed
• The pre-market and post-market pathways

Under EU MDR, a device’s Intended Purpose (MDR term) is the first step in assigning classification rules. Under FDA, Intended Use helps determine whether a 510(k), De Novo, PMA, or exemption applies.

2. What Are Indications for Use?

Indications for Use provide specific details about the circumstances in which the device can be used. They describe who, when, how, and for what medical condition the device is used.

Indications for Use answer:

“In which situations is the device to be used?”

They include:

• Disease or condition
• Patient population (age, comorbidities)
• Target anatomy
• Clinical context or setting
• Level of severity
• Intended user (HCP, trained technician, layperson)
• Environment of use (hospital, home, ICU, ambulance)

Example (Detailed Use):

For a thermometer:
“Indicated for measuring body temperature in pediatric and adult patients in home and clinical settings.”

For a stent:
“Indicated for patients with coronary artery disease requiring restoration of blood flow in narrowed coronary arteries.”

Why Indications Are Critical

Indications for Use appear in:

• Labeling
• IFU/user manuals
• Packaging
• Marketing materials
• Clinical evaluation reports

Regulators use Indications to evaluate:

• Benefit–risk per intended patient group
• Required level of clinical evidence
• PMS and PMCF plans
• Device classification alignment
• Ethical needs for patient-specific claims

If Indications are written too broadly, regulators may ask for additional clinical evidence. If written too narrowly, the manufacturer may underutilize potential market reach.

3. Key Differences Between Intended Use and Indications for Use

Although related, the two terms differ in scope and specificity.

A useful analogy:
Intended Use is the title of a book.
Indications for Use are the chapters inside the book.

4. How Regulatory Bodies Define These Terms

EU MDR

EU MDR uses the term Intended Purpose, defined under Article 2. It captures both the general function and sometimes the specifics depending on device type. EU MDR expects textual clarity within the Technical Documentation, IFU, and clinical evaluation.

Indications for Use are not explicitly defined in MDR but are expected as part of:

• Clinical evaluation
• Labeling
• Instructions for use
• PMS plans

US FDA

The FDA distinctly separates the two:

• Intended Use: General purpose or function.
• Indications for Use: Disease, condition, or patient population.

FDA requires a specific Indications for Use Statement for all 510(k) submissions.

CDSCO (India)

CDSCO aligns more with the FDA approach.
During MD-5, MD-14, or import licensing:

• Intended Use (Purpose of Device) is broad.
• Indications for Use (Clinical context) must be justified.

5. Practical Examples to Understand the Difference

Example: Blood Pressure Monitor

Intended Use:
To measure arterial blood pressure.

Indications for Use:
Indicated for measuring systolic and diastolic blood pressure in adult patients in home or clinical settings. Not recommended for neonates.

Example: Orthopedic Cast

Intended Use:
To immobilize fractured or injured limbs.

Indications for Use:
Indicated for immobilizing simple fractures in pediatric and adult upper or lower limbs, used under clinical supervision.

Example: Surgical Mask

Intended Use:
To provide a physical barrier to prevent transfer of microorganisms, body fluids, and particulate material.

Indications for Use:
Indicated for use by healthcare personnel during surgical procedures, patient care, and routine medical settings to reduce exposure to airborne particles and fluids.

6. Why Manufacturers Must Clearly Define Both

1. Accurate Classification

Vague Intended Use statements may shift device classification unnecessarily upward or result in regulatory queries.

2. Clinical Evaluation Clarity

Indications for Use guide:

• Literature selection
• Equivalence justification
• PMCF needs
• Clinical data sufficiency

3. Labeling & Promotion Safety

Marketing teams often unintentionally expand indications—leading to non-compliance.

4. Prevents Off-Label Use

Clear indications prevent misuse, safety risk, and legal liability.

5. Foundation for Post-Market Surveillance

Well-defined use scenarios help:

• Track adverse events
• Identify misuse patterns
• Define PMCF triggers
• Improve risk management files

7. Conclusion

Understanding the difference between Intended Use and Indications for Use is essential for ensuring regulatory compliance, achieving smoother approvals, and creating accurate, safe, and effective labeling. While Intended Use defines the general purpose of a device, Indications for Use detail the specific clinical scenarios where the device is applied.

Getting these two definitions right early in the design and documentation process sets the foundation for:

• Proper classification
• Successful regulatory submissions
• Accurate clinical evidence strategy
• Clear, safe labeling
• Compliance throughout the device lifecycle

Whether you are drafting a CER, preparing a technical file, or planning a new product launch, clarity between these two terms can save months of delay and ensure regulatory success.